世界の耳がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ear Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4169
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、耳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、外科療法、放射線療法）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・耳がん治療の市場動向
・企業の競争状況、市場シェア
・耳がん治療の種類別市場規模と予測2016-2027（化学療法、免疫療法、外科療法、放射線療法）
・耳がん治療の用途別市場規模と予測2016-2027（病院、診療所、外来外科センター、その他）
・耳がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・耳がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・耳がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・耳がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・耳がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bristol-Myers Squibb、Oncology Venture、Merck、GSK、Amgen、Roche、Teva Pharmaceuticals、Sun Pharmaceutical、AbbVie、Novartis、Regeneron Pharmaceuticals、AstraZeneca、Eli Lilly and Company）
・結論

Market Analysis and Insights: Global Ear Cancer Treatment Market
The global Ear Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ear Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ear Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ear Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ear Cancer Treatment market.

Global Ear Cancer Treatment Scope and Market Size
Ear Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ear Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Immunotherapy
Surgical Therapy
Radiation Therapy

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb
Oncology Venture
Merck
GSK
Amgen
Roche
Teva Pharmaceuticals
Sun Pharmaceutical
AbbVie
Novartis
Regeneron Pharmaceuticals
AstraZeneca
Eli Lilly and Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ear Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Surgical Therapy
1.2.5 Radiation Therapy
1.3 Market by Application
1.3.1 Global Ear Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ear Cancer Treatment Market Perspective (2016-2027)
2.2 Ear Cancer Treatment Growth Trends by Regions
2.2.1 Ear Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ear Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ear Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ear Cancer Treatment Industry Dynamic
2.3.1 Ear Cancer Treatment Market Trends
2.3.2 Ear Cancer Treatment Market Drivers
2.3.3 Ear Cancer Treatment Market Challenges
2.3.4 Ear Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ear Cancer Treatment Players by Revenue
3.1.1 Global Top Ear Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Ear Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ear Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ear Cancer Treatment Revenue
3.4 Global Ear Cancer Treatment Market Concentration Ratio
3.4.1 Global Ear Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ear Cancer Treatment Revenue in 2020
3.5 Ear Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Ear Cancer Treatment Product Solution and Service
3.7 Date of Enter into Ear Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ear Cancer Treatment Breakdown Data by Type
4.1 Global Ear Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ear Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Ear Cancer Treatment Breakdown Data by Application
5.1 Global Ear Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ear Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ear Cancer Treatment Market Size (2016-2027)
6.2 North America Ear Cancer Treatment Market Size by Type
6.2.1 North America Ear Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Ear Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Ear Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Ear Cancer Treatment Market Size by Application
6.3.1 North America Ear Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Ear Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Ear Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Ear Cancer Treatment Market Size by Country
6.4.1 North America Ear Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Ear Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ear Cancer Treatment Market Size (2016-2027)
7.2 Europe Ear Cancer Treatment Market Size by Type
7.2.1 Europe Ear Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ear Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ear Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Ear Cancer Treatment Market Size by Application
7.3.1 Europe Ear Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ear Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ear Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Ear Cancer Treatment Market Size by Country
7.4.1 Europe Ear Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ear Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ear Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ear Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Ear Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ear Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ear Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ear Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Ear Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ear Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ear Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ear Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Ear Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ear Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ear Cancer Treatment Market Size (2016-2027)
9.2 Latin America Ear Cancer Treatment Market Size by Type
9.2.1 Latin America Ear Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ear Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ear Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Ear Cancer Treatment Market Size by Application
9.3.1 Latin America Ear Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ear Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ear Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Ear Cancer Treatment Market Size by Country
9.4.1 Latin America Ear Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ear Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ear Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ear Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Ear Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ear Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ear Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ear Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Ear Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ear Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ear Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ear Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Ear Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ear Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Ear Cancer Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Ear Cancer Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Oncology Venture
11.2.1 Oncology Venture Company Details
11.2.2 Oncology Venture Business Overview
11.2.3 Oncology Venture Ear Cancer Treatment Introduction
11.2.4 Oncology Venture Revenue in Ear Cancer Treatment Business (2016-2021)
11.2.5 Oncology Venture Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Ear Cancer Treatment Introduction
11.3.4 Merck Revenue in Ear Cancer Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Ear Cancer Treatment Introduction
11.4.4 GSK Revenue in Ear Cancer Treatment Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Ear Cancer Treatment Introduction
11.5.4 Amgen Revenue in Ear Cancer Treatment Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Ear Cancer Treatment Introduction
11.6.4 Roche Revenue in Ear Cancer Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Details
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Ear Cancer Treatment Introduction
11.7.4 Teva Pharmaceuticals Revenue in Ear Cancer Treatment Business (2016-2021)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Ear Cancer Treatment Introduction
11.8.4 Sun Pharmaceutical Revenue in Ear Cancer Treatment Business (2016-2021)
11.8.5 Sun Pharmaceutical Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Ear Cancer Treatment Introduction
11.9.4 AbbVie Revenue in Ear Cancer Treatment Business (2016-2021)
11.9.5 AbbVie Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Ear Cancer Treatment Introduction
11.10.4 Novartis Revenue in Ear Cancer Treatment Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Regeneron Pharmaceuticals
11.11.1 Regeneron Pharmaceuticals Company Details
11.11.2 Regeneron Pharmaceuticals Business Overview
11.11.3 Regeneron Pharmaceuticals Ear Cancer Treatment Introduction
11.11.4 Regeneron Pharmaceuticals Revenue in Ear Cancer Treatment Business (2016-2021)
11.11.5 Regeneron Pharmaceuticals Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Ear Cancer Treatment Introduction
11.12.4 AstraZeneca Revenue in Ear Cancer Treatment Business (2016-2021)
11.12.5 AstraZeneca Recent Development
11.13 Eli Lilly and Company
11.13.1 Eli Lilly and Company Company Details
11.13.2 Eli Lilly and Company Business Overview
11.13.3 Eli Lilly and Company Ear Cancer Treatment Introduction
11.13.4 Eli Lilly and Company Revenue in Ear Cancer Treatment Business (2016-2021)
11.13.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ear Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Surgical Therapy
Table 5. Key Players of Radiation Therapy
Table 6. Global Ear Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ear Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ear Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ear Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Ear Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ear Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Ear Cancer Treatment Market Trends
Table 13. Ear Cancer Treatment Market Drivers
Table 14. Ear Cancer Treatment Market Challenges
Table 15. Ear Cancer Treatment Market Restraints
Table 16. Global Ear Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ear Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Ear Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ear Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Ear Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ear Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ear Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Ear Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ear Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Ear Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ear Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ear Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ear Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Ear Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ear Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ear Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ear Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ear Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ear Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ear Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ear Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ear Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ear Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ear Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ear Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ear Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ear Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ear Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ear Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ear Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ear Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ear Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ear Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ear Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ear Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ear Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ear Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ear Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ear Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ear Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ear Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol-Myers Squibb Company Details
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Ear Cancer Treatment Product
Table 66. Bristol-Myers Squibb Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Oncology Venture Company Details
Table 69. Oncology Venture Business Overview
Table 70. Oncology Venture Ear Cancer Treatment Product
Table 71. Oncology Venture Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Oncology Venture Recent Development
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Ear Cancer Treatment Product
Table 76. Merck Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Merck Recent Development
Table 78. GSK Company Details
Table 79. GSK Business Overview
Table 80. GSK Ear Cancer Treatment Product
Table 81. GSK Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. GSK Recent Development
Table 83. Amgen Company Details
Table 84. Amgen Business Overview
Table 85. Amgen Ear Cancer Treatment Product
Table 86. Amgen Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Amgen Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Ear Cancer Treatment Product
Table 91. Roche Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Teva Pharmaceuticals Company Details
Table 94. Teva Pharmaceuticals Business Overview
Table 95. Teva Pharmaceuticals Ear Cancer Treatment Product
Table 96. Teva Pharmaceuticals Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Teva Pharmaceuticals Recent Development
Table 98. Sun Pharmaceutical Company Details
Table 99. Sun Pharmaceutical Business Overview
Table 100. Sun Pharmaceutical Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Sun Pharmaceutical Recent Development
Table 102. AbbVie Company Details
Table 103. AbbVie Business Overview
Table 104. AbbVie Ear Cancer Treatment Product
Table 105. AbbVie Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 106. AbbVie Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Ear Cancer Treatment Product
Table 110. Novartis Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Regeneron Pharmaceuticals Company Details
Table 113. Regeneron Pharmaceuticals Business Overview
Table 114. Regeneron Pharmaceuticals Ear Cancer Treatment Product
Table 115. Regeneron Pharmaceuticals Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 116. Regeneron Pharmaceuticals Recent Development
Table 117. AstraZeneca Company Details
Table 118. AstraZeneca Business Overview
Table 119. AstraZeneca Ear Cancer Treatment Product
Table 120. AstraZeneca Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 121. AstraZeneca Recent Development
Table 122. Eli Lilly and Company Company Details
Table 123. Eli Lilly and Company Business Overview
Table 124. Eli Lilly and Company Ear Cancer Treatment Product
Table 125. Eli Lilly and Company Revenue in Ear Cancer Treatment Business (2016-2021) & (US$ Million)
Table 126. Eli Lilly and Company Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ear Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Surgical Therapy Features
Figure 5. Radiation Therapy Features
Figure 6. Global Ear Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Ear Cancer Treatment Report Years Considered
Figure 12. Global Ear Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Ear Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Ear Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Ear Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global Ear Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top Ear Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ear Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Ear Cancer Treatment Revenue in 2020
Figure 19. Global Ear Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Ear Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Ear Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America Ear Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America Ear Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ear Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe Ear Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe Ear Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ear Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Ear Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Ear Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ear Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Ear Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Ear Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ear Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Ear Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Ear Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Ear Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 61. Oncology Venture Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 67. Sun Pharmaceutical Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 70. Regeneron Pharmaceuticals Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 72. Eli Lilly and Company Revenue Growth Rate in Ear Cancer Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の声門がん治療市場規模・現状・予測（2021年-2027年）

Global Glottic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4258 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、声門がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術治療、薬物治療）、用途別市場規模（病院、クリニック、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の胃がん治療市場規模・現状・予測（2021年-2027年）

Global Stomach Cancer and Gastric Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6022 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、胃がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プログラム細胞死タンパク質1（PD-1）阻害剤、ヒト上皮成長因子受容体（HER2）拮抗薬、血管内皮増殖因子受容体（VEGFR）拮抗薬、その他）...

世界のALK陽性肺がん治療市場規模・現状・予測（2021年-2027年）

Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5075 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ALK陽性肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリゾチニブ、アレクチニブ、セリチニブ、ブリグチニブ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、ア...

世界の精巣がん治療市場規模・現状・予測（2021年-2027年）

Global Testicular Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4948 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、精巣がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、経口剤）、用途別市場規模（病院薬局、小売薬局、専門がんクリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4496 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、転移性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4497 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、転移性結腸直腸癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科、化学療法）、用途別市場規模（病院、クリニック、がん研究センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年）

Global Muscle Invasive Bladder Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5259 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、筋層浸潤性膀胱がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ネオアジュバント化学療法、術後化学療法）、用途別市場規模（病院、研究所、専門クリニック）、主要地域別市場規模（北米、アメリカ、欧州...

世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の上皮性卵巣がん治療市場規模・現状・予測（2021年-2027年） Epithelial ovarian cancer is a disease in which malignant cells develop in the tissue that covers the ovary. Epithelial ovarian cancer is common in women who have a close relation such as mother, daughter, or sister diagnosed with the disease. Market Analysis and Insights: Global Epithelial Ovarian …
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…
世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年） An abnormal mass of tissue that usually does not contain cysts or liquid areas. Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% dur…